BioSenic provides update regarding current license agreement

INSIDE INFORMATION Maintenance of the license is now subject to the launch of the OATO Phase III before May 2024 instead of 31 May 2023 Parties also currently negotiating a potential renegotiation... | May 29, 2023

Related Keywords

France , Canada , Belgium , Mont Saint Guibert , Waals Gewest , Paris , France General , Australia , Belgian , French , Australian , Australians , Ghislaine Gasparetto , Bert Bouserie , Neil Hunter Michelle Boxall , Annie Florence Loyer , Seitosei Actifin , Phebra Pty Ltd , International Media Enquiries , Ib Communications , Biosenic Group , Euronext Brussels , Graft Versus Host Disease , Systemic Sclerosis , Systemic Lupus Erythematosus , Medsenic Territories , Chief Executive Officer , South Americas , Arsenic Trioxide , Host Disease , Louvain La Neuve Science Park , Mesenchymal Stromal Cells , Systemic Lupus , Chief Executive , Belgian Media , Investor Enquiries , French Media Enquiries , French Investor Enquiries , Biosenic Sa Stock Exchange , News , Information , Press Release , Inside , Maintenance , F , The , License , Us , Dow , Subject , O , Launch , Nato , Hase , Wii , Before , Bay , 024 , Unstead , 1 , 023 , Parties , Also , Currently , Negotiating , Otential Bios Be0974280126 ,